Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,047 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Authors' reply.
Ballantyne CM, Bays HE, Braeckman RA, Soni PN. Ballantyne CM, et al. Am J Cardiol. 2013 Feb 1;111(3):455-6. doi: 10.1016/j.amjcard.2012.11.036. Am J Cardiol. 2013. PMID: 23317532 No abstract available.
Icosapent ethyl for the treatment of hypertriglyceridemia.
Ballantyne CM, Braeckman RA, Soni PN. Ballantyne CM, et al. Expert Opin Pharmacother. 2013 Jul;14(10):1409-16. doi: 10.1517/14656566.2013.798645. Epub 2013 May 24. Expert Opin Pharmacother. 2013. PMID: 23701295
Efficacy and safety of a novel dual modulator of adenosine triphosphate-citrate lyase and adenosine monophosphate-activated protein kinase in patients with hypercholesterolemia: results of a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial.
Ballantyne CM, Davidson MH, Macdougall DE, Bays HE, Dicarlo LA, Rosenberg NL, Margulies J, Newton RS. Ballantyne CM, et al. J Am Coll Cardiol. 2013 Sep 24;62(13):1154-62. doi: 10.1016/j.jacc.2013.05.050. Epub 2013 Jun 13. J Am Coll Cardiol. 2013. PMID: 23770179 Free article. Clinical Trial.
Effects of icosapent ethyl on lipid and inflammatory parameters in patients with diabetes mellitus-2, residual elevated triglycerides (200-500 mg/dL), and on statin therapy at LDL-C goal: the ANCHOR study.
Brinton EA, Ballantyne CM, Bays HE, Kastelein JJ, Braeckman RA, Soni PN. Brinton EA, et al. Among authors: ballantyne cm. Cardiovasc Diabetol. 2013 Jul 9;12:100. doi: 10.1186/1475-2840-12-100. Cardiovasc Diabetol. 2013. PMID: 23835245 Free PMC article. Clinical Trial.
The editor's roundtable: hypertriglyceridemia.
Friedewald VE, Ballantyne CM, Bays HE, Jones PH. Friedewald VE, et al. Among authors: ballantyne cm. Am J Cardiol. 2013 Oct 15;112(8):1133-41. doi: 10.1016/j.amjcard.2013.07.033. Am J Cardiol. 2013. PMID: 24079443 No abstract available.
1,047 results